Favorable effect of immunomodulator therapy on bone mineral density in multiple sclerosis.

Shuhaibar, M; McKenna, M J; Au-Yeong, M; Redmond, J M T

Shuhaibar, M; McKenna, M J; Au-Yeong, M; Redmond, J M T.

Affiliation

Shuhaibar M; Department of Neurology, St. James's Hospital, Dublin, Ireland.

Ir J Med Sci ; 178(1): 43-5, 2009 Mar.

Article in En | MEDLINE | ID: mdl-19002746

Subject(s)

Adrenal Cortex Hormones/therapeutic use; Bone Density/drug effects; Immunologic Factors/therapeutic use; Immunosuppressive Agents/therapeutic use; Interferon-beta/therapeutic use; Multiple Sclerosis/complications; Osteoporosis/etiology; Peptides/therapeutic use; Absorptiometry, Photon; Adjuvants, Immunologic/therapeutic use; Adult; Confidence Intervals; Female; France; Glatiramer Acetate; Humans; Interferon beta-1a; Interferon beta-1b; Ireland; Male; Multiple Sclerosis/physiopathology; Osteoporosis/drug therapy; Osteoporosis/prevention & control; Spain

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Osteoporosis / Peptides / Bone Density / Interferon-beta / Adrenal Cortex Hormones / Immunologic Factors / Immunosuppressive Agents / Multiple Sclerosis Country/Region as subject: Europa Language: En Journal: Ir J Med Sci Year: 2009 Type: Article Affiliation country: Ireland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google